Sanjeev Narula
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-10-06–present
-
Phathom Pharmaceuticals, Inc. (PHAT)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Phathom Pharmaceuticals, Inc. (PHAT) | Chief Financial and Business Officer | $131,442 | $3,617,962 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.